693 related articles for article (PubMed ID: 22722313)
21. Postscreening follow-up of the Finnish Prostate Cancer Screening Trial on putative prostate cancer risk factors: vitamin and mineral use, male pattern baldness, pubertal development and non-steroidal anti-inflammatory drug use.
Sarre S; Määttänen L; Tammela TL; Auvinen A; Murtola TJ
Scand J Urol; 2016 Aug; 50(4):267-73. PubMed ID: 26927237
[TBL] [Abstract][Full Text] [Related]
22. Aspirin use and ovarian cancer risk using extended follow-up of the PLCO Cancer Screening Trial.
Hurwitz LM; Pinsky PF; Huang WY; Freedman ND; Trabert B
Gynecol Oncol; 2020 Nov; 159(2):522-526. PubMed ID: 32919779
[TBL] [Abstract][Full Text] [Related]
23. The use of aspirin and the risk of mortality in patients with prostate cancer.
Assayag J; Pollak MN; Azoulay L
J Urol; 2015 Apr; 193(4):1220-5. PubMed ID: 25463991
[TBL] [Abstract][Full Text] [Related]
24. Folic acid and risk of prostate cancer: results from a randomized clinical trial.
Figueiredo JC; Grau MV; Haile RW; Sandler RS; Summers RW; Bresalier RS; Burke CA; McKeown-Eyssen GE; Baron JA
J Natl Cancer Inst; 2009 Mar; 101(6):432-5. PubMed ID: 19276452
[TBL] [Abstract][Full Text] [Related]
25. NSAIDs and breast cancer recurrence in a prospective cohort study.
Kwan ML; Habel LA; Slattery ML; Caan B
Cancer Causes Control; 2007 Aug; 18(6):613-20. PubMed ID: 17404892
[TBL] [Abstract][Full Text] [Related]
26. The effects of nonselective non-aspirin non-steroidal anti-inflammatory medications on the risk of nonfatal myocardial infarction and their interaction with aspirin.
Kimmel SE; Berlin JA; Reilly M; Jaskowiak J; Kishel L; Chittams J; Strom BL
J Am Coll Cardiol; 2004 Mar; 43(6):985-90. PubMed ID: 15028354
[TBL] [Abstract][Full Text] [Related]
27. Effect of Aspirin Coadministration on the Safety of Celecoxib, Naproxen, or Ibuprofen.
Reed GW; Abdallah MS; Shao M; Wolski K; Wisniewski L; Yeomans N; Lüscher TF; Borer JS; Graham DY; Husni ME; Solomon DH; Libby P; Menon V; Lincoff AM; Nissen SE
J Am Coll Cardiol; 2018 Apr; 71(16):1741-1751. PubMed ID: 29673465
[TBL] [Abstract][Full Text] [Related]
28. A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence.
Jacobs EJ; Rodriguez C; Mondul AM; Connell CJ; Henley SJ; Calle EE; Thun MJ
J Natl Cancer Inst; 2005 Jul; 97(13):975-80. PubMed ID: 15998950
[TBL] [Abstract][Full Text] [Related]
29. Association of Aspirin Use With Mortality Risk Among Older Adult Participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Loomans-Kropp HA; Pinsky P; Cao Y; Chan AT; Umar A
JAMA Netw Open; 2019 Dec; 2(12):e1916729. PubMed ID: 31800071
[TBL] [Abstract][Full Text] [Related]
30. Aspirin and prostate cancer prevention.
Bosetti C; Rosato V; Gallus S; La Vecchia C
Recent Results Cancer Res; 2014; 202():93-100. PubMed ID: 24531782
[TBL] [Abstract][Full Text] [Related]
31. Maintenance use of aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs) and prostate cancer risk.
Ma Y; Brusselaers N
Prostate Cancer Prostatic Dis; 2018 Apr; 21(1):147-152. PubMed ID: 29259292
[TBL] [Abstract][Full Text] [Related]
32. PPARgamma and colon and rectal cancer: associations with specific tumor mutations, aspirin, ibuprofen and insulin-related genes (United States).
Slattery ML; Curtin K; Wolff R; Ma KN; Sweeney C; Murtaugh M; Potter JD; Levin TR; Samowitz W
Cancer Causes Control; 2006 Apr; 17(3):239-49. PubMed ID: 16489531
[TBL] [Abstract][Full Text] [Related]
33. Effect of ibuprofen on cardioprotective effect of aspirin.
MacDonald TM; Wei L
Lancet; 2003 Feb; 361(9357):573-4. PubMed ID: 12598144
[TBL] [Abstract][Full Text] [Related]
34. Use of non-steroidal anti-inflammatory drugs and prostate cancer risk: a population-based nested case-control study.
Mahmud SM; Franco EL; Turner D; Platt RW; Beck P; Skarsgard D; Tonita J; Sharpe C; Aprikian AG
PLoS One; 2011 Jan; 6(1):e16412. PubMed ID: 21297996
[TBL] [Abstract][Full Text] [Related]
35. Regular Aspirin Use and the Risk of Lethal Prostate Cancer in the Physicians' Health Study.
Downer MK; Allard CB; Preston MA; Gaziano JM; Stampfer MJ; Mucci LA; Batista JL
Eur Urol; 2017 Nov; 72(5):821-827. PubMed ID: 28189429
[TBL] [Abstract][Full Text] [Related]
36. Low-dose aspirin use and cancer characteristics: a population-based cohort study.
Jonsson F; Yin L; Lundholm C; Smedby KE; Czene K; Pawitan Y
Br J Cancer; 2013 Oct; 109(7):1921-5. PubMed ID: 23887604
[TBL] [Abstract][Full Text] [Related]
37. Correlation between prolonged use of aspirin and prognostic risk in prostate cancer.
Dell'Atti L
Tumori; 2014; 100(5):486-90. PubMed ID: 25343540
[TBL] [Abstract][Full Text] [Related]
38. Non-steroidal anti-inflammatory drug and aspirin use and the risk of head and neck cancer.
Wilson JC; Murray LJ; Hughes CM; Black A; Anderson LA
Br J Cancer; 2013 Mar; 108(5):1178-81. PubMed ID: 23449358
[TBL] [Abstract][Full Text] [Related]
39. Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxib.
Farkouh ME; Greenberg JD; Jeger RV; Ramanathan K; Verheugt FW; Chesebro JH; Kirshner H; Hochman JS; Lay CL; Ruland S; Mellein B; Matchaba PT; Fuster V; Abramson SB
Ann Rheum Dis; 2007 Jun; 66(6):764-70. PubMed ID: 17412741
[TBL] [Abstract][Full Text] [Related]
40. Aspirin use and the risk of prostate cancer: a meta-analysis of 24 epidemiologic studies.
Huang TB; Yan Y; Guo ZF; Zhang XL; Liu H; Geng J; Yao XD; Zheng JH
Int Urol Nephrol; 2014 Sep; 46(9):1715-28. PubMed ID: 24687637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
